JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation.

导出 OA

翻译打印收藏纠错

作者： Bärbel,Edelmann ^[1] ; Nibedita,Gupta ^[2] ; Tina M,Schnoeder ^[1] ; Anja M,Oelschlegel ^[2] ; Khurrum,Shahzad ^[1] ; Jürgen,Goldschmidt ^[3] ; Lars,Philipsen ^[4] ; Soenke,Weinert ^[5] ; Aniket,Ghosh ^[6] ; Felix C,Saalfeld ^[7] ; Subbaiah Chary,Nimmagadda ^[5] ; Peter,Müller ^[2] ; Rüdiger,Braun-Dullaeus ^[8] ; Juliane,Mohr ^[2] ; Denise,Wolleschak ^[9] ; Stefanie,Kliche ^[5] ; Holger,Amthauer ^[1] ; Florian H,Heidel ^[2] ; Burkhart,Schraven ^[1] ; Berend,Isermann ^[2] ; Andreas J,Müller ^[1] ; Thomas,Fischer ^[2]

作者单位： Department of Hematology and Oncology, Medical Center, Otto-von-Guericke University, Magdeburg, Germany. ^[1] Gesundheitscampus Immunologie, Infektiologie und Inflammation (GCI3), Medical Center, Otto-von-Guericke University, Magdeburg, Germany. ^[2] Internal Medicine II, Hematology and Oncology, University Hospital Jena, Jena, Germany. ^[3] Leibniz Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany. ^[4] Leibniz Institute for Neurobiology, Magdeburg, Germany. ^[5] Institute of Anatomy. ^[6] Institute of Clinical Chemistry and Pathobiochemistry. ^[7] Institute of Molecular and Clinical Immunology, and. ^[8] Department of Cardiology and Angiology, Medical Center, Otto-von-Guericke University, Magdeburg, Germany. ^[9] Department of Radiology and Nuclear Medicine, University Hospital, Magdeburg, Germany. ^[10] Helmholtz Centre for Infection Research, Department of Immune Control, Braunschweig, Germany. ^[11]

关键词 Hematology Integrins Thrombosis